This inventor holds 2 USPTO granted patents. Top assignee: Macau University of Science and Technology. Active years: 2019-2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019-2021
Title: Weina Gao: Innovator in Autoimmune Disease Biomarkers
Introduction
Weina Gao is an accomplished inventor based in Macau, China, known for her significant contributions to the field of biomedical engineering. With two patents to her name, she has focused her research on the innovative use of glycan biomarkers for the detection of autoimmune diseases, a critical area in medical diagnostics.
Latest Patents
Gao's latest patents, prominently feature her pioneering work in the utilization of glycan biomarkers. The inventions disclose a method for determining the presence of autoimmune diseases through glycan analysis. Furthermore, they introduce an enhanced detection sensitivity method for trace glycans, employing a microfluidic chip designed for this purpose. This technological advancement holds promise for more accurate disease detection and could revolutionize current diagnostic methodologies.
Career Highlights
Weina Gao is affiliated with the Macau University of Science and Technology, where she conducts her research and development efforts. Her work has not only contributed to scientific understanding but also has the potential to influence clinical practices surrounding autoimmune disease diagnosis.
Collaborations
Throughout her career, Gao has collaborated with other notable researchers, including Liang Liu and Jing-Rong Wang. These collaborations have allowed for a richer exchange of ideas and have fostered innovation within her field.
Conclusion
Weina Gao's commitment to improving the detection of autoimmune diseases through her innovative use of glycan biomarkers places her at the forefront of advancements in medical diagnostics. Her contributions to science exemplify the transformative power of innovation in addressing complex health challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile